{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T13:26:16Z","timestamp":1771075576257,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.vaccine.2006.03.051","type":"journal-article","created":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T12:13:31Z","timestamp":1143893611000},"page":"5420-5425","source":"Crossref","is-referenced-by-count":14,"title":["Intranasal immunization of mice with recombinant lipidated P2086 protein reduces nasal colonization of group B Neisseria meningitidis"],"prefix":"10.1016","volume":"24","author":[{"given":"Duzhang","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicki","family":"Barniak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Zlotnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.03.051_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0165-5728(90)90146-E","article-title":"Evidence for autoimmune antibodies directed against embryonic neural cell adhesion molecules (N-CAM) in patients with group B meningitis","volume":"29","author":"Nedelec","year":"1990","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.vaccine.2006.03.051_bib2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","article-title":"Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis","volume":"322","author":"Finne","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2006.03.051_bib3","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/infdis\/126.5.514","article-title":"Immunologic response of man to group B meningococcal polysaccharide vaccines","volume":"126","author":"Wyle","year":"1972","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2006.03.051_bib4","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1128\/IAI.62.10.4419-4424.1994","article-title":"Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy","volume":"62","author":"Milagres","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.03.051_bib5","first-page":"211","article-title":"The Chilean committee for meningococcal disease. Meningococcal serogroup B vaccine protection trial and follow-up studies in Chile","volume":"14","author":"Zollinger","year":"1991","journal-title":"NIPH Ann"},{"key":"10.1016\/j.vaccine.2006.03.051_bib6","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1086\/315833","article-title":"Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992\u20131998","volume":"182","author":"Sacchi","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2006.03.051_bib7","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1128\/JCM.38.9.3323-3328.2000","article-title":"Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States","volume":"38","author":"Tondella","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2006.03.051_bib8","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","article-title":"Vaccine potential of the Neisseria meningitidis 2086 lipoprotein","volume":"72","author":"Fletcher","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.03.051_bib9","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.vaccine.2005.01.056","article-title":"Outer membrane protein (OMP) based vaccine for Neisseria meningitidis serogroup B","volume":"23","author":"Pillai","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.03.051_bib10","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1128\/IAI.73.10.6838-6845.2005","article-title":"Evaluation of recombinant lipidated P2086 protein as a vaccine candidate for group B Neisseria meningitidis in a murine nasal challenge model","volume":"73","author":"Zhu","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.03.051_bib11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870","volume":"197","author":"Masignani","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2006.03.051_bib12","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1016\/j.vaccine.2004.02.027","article-title":"Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4\/rLP6\/UspA2 proteins combined with aqueous formulation of RC529","volume":"22","author":"Mason","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.03.051_bib13","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/IAI.73.2.981-989.2005","article-title":"PppA, a surface-exposed protein of Streptococcus pneumoniae, elicits cross-reactive antibodies that reduce colonization in a murine intranasal immunization and challenge model","volume":"73","author":"Green","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.03.051_bib14","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1128\/IAI.72.7.4052-4060.2004","article-title":"Mucosal vaccination against serogroup B meningococci: Induction of bactericidal antibodies and cellular immunity following intranasal immunization with NadA of Neisseria meningitidis and mutants of Escherichia coli heat-labile enterotoxin","volume":"72","author":"Bowe","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.03.051_bib15","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1128\/IAI.70.2.702-707.2002","article-title":"Immunogenicity and safety testing of a group B intranasal meningococcal native outer membrane vesicle vaccine","volume":"70","author":"Katial","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.03.051_bib16","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1016\/S0264-410X(01)00229-8","article-title":"Passive immunization with Neisseria meningitidis PorA specific immune sera reduces nasopharyngeal colonization of group B meningococcus in an infant rat nasal challenge model","volume":"19","author":"Schimidt","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.03.051_bib17","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/JB.85.6.1274-1279.1963","article-title":"Neisseria gonorrhoeae. I. Virulence genetically linked to clonal variation","volume":"85","author":"Kellogg","year":"1963","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2006.03.051_bib18","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1128\/JB.43.6.757-761.1942","article-title":"Growth requirements of the meningococcus","volume":"43","author":"Frantz","year":"1942","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2006.03.051_bib19","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1016\/S0264-410X(00)00058-X","article-title":"Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H","volume":"18","author":"Tebbey","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.03.051_bib20","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1086\/344233","article-title":"Immunization with Haemophilus influenzae Hap adhesin protects against nasopharyngeal colonization in experimental mice","volume":"186","author":"Cutter","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2006.03.051_bib21","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1128\/JCM.38.8.2878-2884.2000","article-title":"Detection of complement-mediated antibody-dependent bactericidal activity in a fluorescence-based serum bactericidal assay for group B Neisseria meningitidis","volume":"38","author":"Mountzouros","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2006.03.051_bib22","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0264-410X(94)90112-0","article-title":"New strategies for using mucosal vaccination to achieve more effective immunization","volume":"12","author":"Walker","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.03.051_bib23","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1128\/JCM.38.9.3323-3328.2000","article-title":"Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States","volume":"38","author":"Tondella","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2006.03.051_bib24","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1084\/jem.129.6.1327","article-title":"Human immunity to the meningococcus. II. Development of natural immunity","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2006.03.051_bib25","first-page":"41","article-title":"Intranasal vaccination against diphtheria and tetanus in human subjects","volume":"6","author":"Gizurarson","year":"1997","journal-title":"Vaccine Res"},{"key":"10.1016\/j.vaccine.2006.03.051_bib26","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1128\/IAI.5.4.627-629.1972","article-title":"Serum and nasal secretion immune response in meningococcal disease","volume":"5","author":"Wenzel","year":"1972","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.03.051_bib27","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1128\/IAI.66.4.1334-1341.1998","article-title":"Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans","volume":"66","author":"Haneberg","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.03.051_bib28","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2006.03.051_bib29","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/IAI.69.3.1568-1573.2001","article-title":"Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection","volume":"69","author":"Borrow","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.03.051_bib30","unstructured":"Lang D. Safety evaluation of toxin adjuvants delivered intranasally; 2001 [online-http:\/\/www.niaid.nih.gov\/dmid\/enteric\/intranasal.htm]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06003719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06003719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,13]],"date-time":"2020-04-13T13:30:18Z","timestamp":1586784618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06003719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":30,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0264410X06003719"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.03.051","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}